-
Mashup Score: 0Renin-Angiotensin System Modulation in Adults With COVID-19 - 1 year(s) ago
These 2 randomized clinical trials compare the efficacy and safety of renin-angiotensin system (RAS) modulation using 2 investigational RAS agents, TXA-127 vs placebo and TRV-027 vs placebo, in adults hospitalized with severe COVID-19.
Source: jamanetwork.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
The renin-angiotensin-aldosterone system (RAAS), whose major vasopressor effector is angiotensin II (ATII), has multiple activities and regulates sodium-water homeostasis and fluid and blood pressure homeostasis. RAAS plays a crucial role in cardiocirculatory shock because it counteracts hypotension and hypovolemia by activating different physiologic responses. Based on the encouraging results of…
Categories: Anesthesiology, Latest HeadlinesTweet-
The use of #angiotensin II in patients with #COVID19 showed promising results because its administration was associated with the achievement and maintenance of target mean arterial pressure, increased PaO2/FIO2 ratio, and decreased FIO2. https://t.co/ThYWG4IqUp https://t.co/OY4IvtG6pO
-
-
Mashup Score: 2
People with AVRI using ACEi/ARBs for HTN had a greater increase in poor outcomes during the COVID-19 pandemic than those using other medications to treat HTN. The small absolute magnitude of the differences likely does not support changes in clinical practice.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet-
Association of outpatient use of #renin- #angiotensin- #aldosterone #system #blockers on outcomes of #acute #respiratory #illness during the #COVID-19 #pandemic: a cohort study https://t.co/HyUFFKAtgM https://t.co/c7ZUGmOVqE
-
-
Mashup Score: 17Angiotensin II: A Review of Current Literature - 2 year(s) ago
Up to one-third of all patients admitted to intensive care units carry a diagnosis of shock. The use of angiotensin II is becoming widespread in all forms of shock, including cardiogenic, after the U.S. Food and Drug Administration’s (FDA’s) initial approval for vasoplegic shock in 2017. Here, the authors review the literature on angiotensin II’s mechanism of action, benefits, and future…
Categories: Anesthesiology, Latest HeadlinesTweet-
✅1/3 of all patients admitted to ICU carry a diagnosis of shock. The use of angiotensin II is becoming widespread in all forms of #shock. ✅Reviewed the literature on #angiotensin II's mechanism of action, benefits, and future therapeutic opportunities. https://t.co/uG9YDTBhb4 https://t.co/q34GnkWwfZ
-
-
Mashup Score: 1Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored - Critical Care - 2 year(s) ago
Critical Care volume 25, Article number: 389 (2021) Cite this article …
Source: Critical CareCategories: Critical Care, Latest HeadlinesTweet-
#CritCare #OpenAccess Mind the #RAAS in critically ill patients! https://t.co/UrcvF1cB70 #FOAMed #FOAMcc #BMC #ICU #IntensiveCare #renin #angiotensin #aldosterone @jlvincen @ISICEM https://t.co/06D7N8lc1A
-
-
Mashup Score: 0
Angiotensin-converting enzyme inhibitor (ACEI) is a class of medication well known not only for its cardiovascular benefits but also for respiratory adverse effects. In the late 1970s, captopril, one of the first orally active ACEIs, demonstrated clinical effectiveness in patients with hypertension or congestive heart failure. However, respiratory side effects, particularly cough, became widely…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! #Angiotensin- #Converting #Enzyme #Inhibitors, #Asthma, and #Cough: Relighting the Torch https://t.co/NKF4S4nxtD
-
-
Mashup Score: 0Intolerance to Angiotensin Converting Enzyme Inhibitors in Asthma and the General Population: A UK Population-Based Cohort Study - 3 year(s) ago
Angiotensin converting enzyme inhibitor (ACEI) intolerance commonly occurs, requiring switching to an angiotensin-II receptor blocker (ARB). Angiotensin converting enzyme inhibitor intolerance may be mediated by bradykinin, potentially affecting airway hyperresponsiveness.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! Intolerance to #Angiotensin #Converting #Enzyme #Inhibitors in #Asthma and the General Population: A UK Population-Based Cohort Study https://t.co/s4QxnXUjgf https://t.co/BPnzOMKF8y
-
-
Mashup Score: 0
Among participants with spirometry confirmed COPD or baseline emphysema, ACEi/ARB use was associated with slower progression of emphysema and lung function decline.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet-
#Emphysema progression and #lung function decline among #angiotensin converting #enzyme #inhibitors ( #ACEi) and #angiotensin- #receptor #blockade ( #ARB) users in the #COPDGene® Cohort https://t.co/htWFf32flj https://t.co/0ilaDFLYBa
-
-
Mashup Score: 2Intolerance to angiotensin converting enzyme inhibitors in asthma and the general population: a UK population-based cohort study - 3 year(s) ago
Angiotensin converting enzyme inhibitor (ACEI) intolerance commonly occurs requiring switching to an angiotensin-II receptor blocker (ARB). ACEI intolerance may be mediated by bradykinin potentially affecting airway hyper-responsiveness.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! Intolerance to #angiotensin converting #enzyme #inhibitors in #asthma and the general population: a UK population-based cohort study https://t.co/s4QxnXUjgf
-
-
Mashup Score: 0Wolters Kluwer Health - 3 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: journals.lww.comCategories: Latest Headlines, RheumatologyTweet-
Check out another article from the #neuroimmune interactions special issue: #Angiotensin receptors and #neuropathicpain. @AndrewShep82 https://t.co/Szj0uOcLMU #PAINReports https://t.co/nriEuvYUn1
-
#Renin-Angiotensin System Modulation With #Synthetic #Angiotensin (1-7) and Angiotensin II Type 1 #Receptor–Biased Ligand in Adults With #COVID19 https://t.co/vX87EOeYtD https://t.co/TCcIFgKhJZ